Delta 9 Cannabis Inc. (DLTNF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Winnipeg, MB, Canada. The current CEO is John William Arbuthnot IV.
DLTNF has IPO date of 2017-11-06, 200 full-time employees, listed on the Other OTC, a market capitalization of $3.04M.
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. As of April 20, 2022, the company owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.
